If you made any changes in Pure these will be visible here soon.

Personal profile

Research areas

  • Neurology
  • Movement disorders - Functional Neurological Symptoms

Fingerprint Dive into the research topics where Michael Binzer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Cerebrospinal fluid Chemical Compounds
Cerebrospinal Fluid Medicine & Life Sciences
Denmark Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Metabolites Chemical Compounds
Kynurenine Medicine & Life Sciences
Dihydroxyphenylalanine Chemical Compounds
Levodopa Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 10 Journal article
  • 7 Poster
  • 2 Conference abstract in journal
  • 1 Review

Diagnostik og behandling af funktionel svimmelhed i henhold til de nye ICD-11-kriterier

Translated title of the contribution: Diagnostics and treatment of functional dizziness in accordance with the new ICD-11 criteriaSaied, M., Vasarhelyi, C. C., Mamoei, S., Stenager, E., Stenager, E., Stone, J. & Binzer, M., 11. Nov 2019, In : Ugeskrift for Laeger. 181, V04190245.

Research output: Contribution to journalJournal articleResearchpeer-review

Dizziness
International Classification of Diseases

Funktionelle symptomer inden for neurologien og den positive diagnostiske proces

Translated title of the contribution: Functional neurological symptoms and the positive diagnostic processHansen, A. S., Mikkelsen, M. B., Stenager, E., Stenager, E., Binzer, M. & Stone, J., 2018, In : Ugeskrift for Laeger. 180, 20, V08170594.

Research output: Contribution to journalJournal articleResearchpeer-review

Neurology
General Practice
Neurologists

Cerebrospinal fluid biomarkers for Parkinson's disease: a systematic review

Dammann Andersen, A., Binzer, M., Stenager, E. & Gramsbergen, J. B., 2017, In : Acta Neurologica Scandinavica. 135, 1, p. 34-56

Research output: Contribution to journalReviewResearchpeer-review

Parkinson Disease
Cerebrospinal Fluid
Neurodegenerative Diseases
Intermediate Filaments
Uric Acid

Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia

Dammann Andersen, A., Blaabjerg, M., Binzer, M., Kamal, A., Thagesen, H., Kjær, T. W., Stenager, E. & Gramsbergen, J. B. P., 2017, In : Journal of Neurochemistry. 141, 4, p. 614-625

Research output: Contribution to journalJournal articleResearchpeer-review

Cerebrospinal fluid
Dihydroxyphenylalanine
Levodopa
Metabolites
Catecholamines

Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia

Havelund, J. F., Dammann Andersen, A., Binzer, M., Blaabjerg, M., Heegaard, N. H. H., Stenager, E., Faergeman, N. J. & Gramsbergen, J. B., 2017, In : Journal of Neurochemistry. 142, 5, p. 756–766

Research output: Contribution to journalJournal articleResearchpeer-review

Kynurenine
Metabolism
Cerebrospinal fluid
Plasmas
Metabolites